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Longitudinal study of changes in 
γδ T cells and CD4+ T cells upon 
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Indonesian children
Sanne E. de Jong  1, Vera E. R. Asscher1, Linda J. Wammes1,6, Aprilianto E. Wiria  1,2, Firdaus 
Hamid1,3, Erliyani Sartono1, Taniawati Supali2, Hermelijn H. Smits1, Adrian J. F. Luty4,5 & 
Maria Yazdanbakhsh  1
Both γδ T cells and CD4+ T cells have been implicated in immunity to malaria, but their association with 
natural gain or loss of infection has not been studied before. Therefore, we followed up asymptomatic 
children living in an area endemic for malaria in Indonesia for 21 months. The percentage of γδ T cells 
was related to both current and previous infection, with higher percentages in infected than uninfected 
children and declining after infections resolve. Infected children also had higher levels of Th1 and Th17 
cells, lower levels of CD25Hi FOXP3+ regulatory T cells (Tregs), but similar levels of Th2 cells as compared 
to uninfected children. However, TNF, IFN-γ, and IL-17 cytokine responses to Plasmodium falciparum-
infected red blood cells (PfRBCs) were similar, while IL-5 and IL-13 responses were lower in infected 
children. Furthermore, infected children had more phenotypically exhausted PD-1+ CD4+ T cells, more 
Tregs expressing TNF-RII, and higher IL-10 responses to PfRBCs, which persisted following resolution of 
infection. Altogether, this study demonstrates that asymptomatic malaria infection is associated with 
some long-lasting changes in the frequencies and immunoregulation of circulating innate and adaptive 
T cells, which might in part explain how pre-exposure to malaria affects responses to subsequent 
immunological challenges.
In areas where malaria is endemic, immune responses can develop upon repeated exposure that lead not only to 
control of parasites, but also symptoms1. Moreover, repeated malaria exposure is believed to result in compro-
mised responses to vaccines2. However, neither protective immune responses nor regulatory responses are fully 
understood. Both γδ T cells and CD4+ T cells have been implicated in immunity and tolerance to malaria.
γδ T cells are thought to participate in the innate immune response to malaria infection, for example by pro-
ducing pro-inflammatory cytokines such as IFN-γ and TNF, or by killing blood-stage merozoites directly with 
cytotoxic granulysin3–6. Next to limiting malaria parasites4, changes in γδ T cells might also be involved in the 
modulation of inflammation during malaria infection5. Most studies of the association between malaria and γδ T 
cells have been based on cross-sectional analysis of clinical cases versus controls, with little data on the behaviour 
of these cells longitudinally in asymptomatic subjects.
Another group of cells studied extensively in malaria, the CD4+ T cells, play a central role in immunity to 
malaria parasites. In particular Th1 cells have been described to play an important role in limiting infection7, 
while expression of regulatory T cells (Tregs) as well as regulatory molecules might play a pivotal role in ensuring 
a balanced response whereby inflammation is kept under control8. With respect to the latter, altered levels of 
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PD-1+ (CD279) CD4+ T cells and Tregs have been found in people with acute malaria or in chronically-exposed 
subjects9–11. Moreover, increased expression of TNF-RII (CD120b) on Tregs, which is critical for their stability 
and function, is associated with malaria infection12, 13. However, as for γδ T cells, most studies examining CD4+ T 
cells and their phenotype has been cross-sectional in nature.
In this study, we investigate the role of γδ T cells and CD4+ T cells in immune responses during natural 
malaria infection. Asymptomatic infected and uninfected Indonesian schoolchildren were followed up over time 
and cell percentages, cytokine responses, and immunoregulation were monitored.
Results
Study population. 123 Indonesian children were followed up for 21 months. Data was available from 77 of these 
children at 9 months and from 115 of these children at 21 months. At baseline, 22.0% of the children were asymp-
tomatically infected with Plasmodium, of which 66.7% carried P. falciparum, 33.3% P. vivax, and 11.1% P. malariae 
(including co-infections with two species) based on PCR diagnosis (Supplementary Table S1). The prevalence remained 
at 22.1% after 9 months and decreased to 8.7% after 21 months, which was ascribed to reinforcement of malaria control 
by the local health centre. Next to malaria infection, 93.3% of all children at baseline was infected with one or more 
helminth species (Supplementary Table S2). Helminth prevalence decreased to 69.6% after 9 months and to 74.3% after 
21 months, and was comparable between the children with and without malaria infection. Sex ratios (49% male) and 
body mass index (mean 14.6 kg/m2, −1.1 zBMI) were comparable between asymptomatic Plasmodium infected and 
uninfected children, although the infected children were slightly older (mean 9.4 vs. 8.3 years old, P = 0.024).
Asymptomatic infected children have relatively more γδ T cells, Th1 cells, and Th17 cells, but 
comparable or downregulated cytokine responses to PfRBC stimulation. To assess the dynamic 
changes in γδ T cells and CD4+ T cells in response to malaria infection, asymptomatic Plasmodium infected and 
uninfected children were compared during a 21-month follow-up. Infected children had higher percentages of γδ 
T cells at baseline and during follow-up as analysed by linear mixed modelling (Fig. 1a and Supplementary Figs S1a 
and S2a). These higher levels decreased after resolution of infection as shown in Fig. 1b (raw data in Supplementary 
Fig. S3a). Linear mixed modelling predicted that children who had been free of infection for 9 months (negative at 
baseline and at 9 months, indicated by ∆) had lower γδ T cell levels at the 9-month time point than children who had 
recently lost their infection (positive at baseline, negative at 9 months, indicated by ○) (8.2% vs. 4.8%). Regarding γδ 
T cell level predictions for the 21-month time point, children who had been free of infection for 12 months (positive 
at baseline, negative at 9 months and 21 months, indicated by ▲) or for 21 months (negative at baseline, 9 months, 
and 21 months, indicated by ■) had lower γδ T cell levels than children who had recently lost their infection (pos-
itive at baseline and 9 months, negative at 21 months, indicated by ●). Another linear mixed model revealed that 
children who had remained free of infection throughout the study period had the lowest levels as well, and showed 
in addition that those found to be infected at consecutive time points had the highest percentages of γδ T cells, i.e. 
higher than newly infected children (Fig. 1c). This indicates that the presence of malaria infection is associated with 
rising γδ T cells percentages, which wane when the infection is cleared, but leaves at least a temporary footprint of a 
higher γδ T cell percentage compared to those who have been free of infection.
When comparing the percentage of total CD4+ T cells, there was no significant difference between infected and 
uninfected children at baseline or during follow-up, neither a change between time points after resolution of infec-
tion (Fig. 1a, d, and e and Supplementary Figs S1b, S2b, and S3b). However, the CD4+ T cell subset composition was 
altered by infection. The percentage of T-bet+ (Th1) and RORγt+ (Th17) CD4+ T cells was higher in infected chil-
dren than in uninfected children, either at baseline or during follow-up (Fig. 2f and Supplementary Figs S1c and S2c). 
However, unlike γδ T cells, these levels did not decrease after resolution of infection within the study period 
(Supplementary Figs S3g, S3h, and S4a). Therefore, malaria infection seems to result in a long-lasting increase of Th1 
and Th17 cells. The percentage of GATA3+ (Th2) CD4+ T cells was not associated with a change in infection status.
We subsequently compared peripheral blood mononuclear cell (PBMC) cytokine responses to in vitro stim-
ulation with P. falciparum-infected red blood cells (PfRBC) between infected and uninfected children, but 
found no significant differences for TNF, IFN-γ, and IL-17 levels in supernatant at any study time point (Fig. 1g 
and Supplementary Figs S1d, S2d, and S4b). IFN-γ is the hallmark cytokine for Th1 cells and IL-17 for Th17 
cells, while TNF can be produced by both CD4+ T cell subsets and all three cytokines can be produced by γδ T 
cells. Nevertheless, the relatively high levels of γδ T cells, Th1 cells, and Th17 cells in infected children were not 
reflected by higher cytokine responses to PfRBCs. Furthermore, despite similar levels of Th2 cells in infected and 
uninfected children, the Th2 cytokines IL-5 and IL-13 were lower in infected children than in uninfected children 
at baseline and during follow-up, suggesting downregulation of Th2 responses in infected children (Fig. 1g and 
Supplementary Figs S1d, S2d, S3i, S3j, and S4b).
Higher CD4+ T cell exhaustion, Treg activation, and IL-10 responses are associated with 
malaria. To investigate the effects of malaria infection on immunoregulation amongst CD4+ T cells, we 
assessed expression of the exhaustion marker PD-1 on CD4+ T cells, Treg levels, and IL-10 cytokine responses 
to PfRBCs in asymptomatic infected and uninfected children. If altered by malaria infection, this might explain 
why the higher percentages of Th1, Th17, and γδ T cells in infected children were not accompanied by enhanced 
cytokine responses and how the Th2 responses were downregulated.
To begin with, infected children had more phenotypically exhausted CD4+ T cells at baseline and dur-
ing follow-up than uninfected children, based both on the percentage of PD-1+ cells and on the expression 
level of PD-1 on CD4+ T cells (Fig. 2a and b and Supplementary Figs S1e and S2e). The exhausted phenotype 
was long-lasting, as the expression did not decrease after resolution of malaria infection (Fig. 2c and d and 
Supplementary Fig. S3c and d).
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Furthermore, in infected children, the percentage of CD25Hi FOXP3+ CD4+ Tregs was lower at baseline and 
during follow-up than in uninfected children (Fig. 2e and Supplementary Figs S1f and S2f). Despite lower Treg 
levels, a higher percentage of these cells expressed TNF-RII in infected children (Fig. 2f and Supplementary 
Figs S1g and S2g), suggesting relatively more Tregs with higher suppressive capacity as compared to Tregs in 
uninfected children. These differences were long-lasting, as the percentage of Tregs or TNF-RII+ Tregs did not 
change significantly after resolution of infection (Fig. 2h and Supplementary Figs S3e and S3f). In addition, 
although not statistically significant, the expression level of TNF-RII on individual Tregs appeared to be higher 
in infected than uninfected children (Fig. 2i and Supplementary Figs S1h and S2h). However, after resolution of 
infection, the expression level of TNF-RII decreased significantly (Fig. 2j), suggesting that although the effects 
on Treg numbers were long-lasting, the expression level of TNF-RII on individual Tregs was only elevated during 
parasitemia. Thus, the expression of TNF-RII seems to be more dynamically associated with presence of malaria 
infection than Treg numbers.
At last, PBMCs of infected children produced more of the regulatory cytokine IL-10 in response to 
in vitro PfRBC stimulation than those of uninfected children, at baseline and during follow-up (Fig. 2k and 
Supplementary Figs S1i and S2i). As the IL-10 levels did not decrease significantly after resolution of infection, 
the increased IL-10 response to PfRBCs appeared long-lasting (Fig. 2l and Supplement S3k).
Discussion
Our results demonstrate that the percentages of γδ T cells were higher in children presenting with asymptomatic 
infections than in uninfected children, and that these levels decreased after clearance of parasites. This is in line 
with other studies in Ethiopia14 and Thailand15 in infected adults who, although presenting with acute malaria, 
had higher levels of γδ T cells than healthy controls. In Ghanaian children and adults, γδ T cell numbers increased 
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Figure 1. Profiles of γδ T cells and CD4+ T cells. (a) The percentage of γδ T cells and CD4+ T cells amongst 
total T cells compared between uninfected and asymptomatic infected children at baseline. Bar graphs show 
means and standard errors of the mean (SEM). (b,d) The percentage of γδ T cells and CD4+ T cells in children 
uninfected at either the 9 (open symbols) or 21 months’ (closed symbols) time point plotted against the time 
period these children were found to be free of infection. Data shown are fixed predicted values (FPVs) of linear 
mixed modelling. The legend shows the malaria infection status at baseline (0 months), and after 9 and 21 
months of follow-up; + indicates infected and - indicates uninfected. The statistical significance of the change in 
cell percentage over time is indicated by the P value. (c,e) The percentage of γδ T cells and CD4+ T cells amongst 
total T cells compared between currently infected (cur.inf.) and/or previously infected (prev.inf.) children, 
i.e. recently and longer-time infected and uninfected children within the study period. (f) The percentage of 
Th1, Th2, and Th17 subsets amongst CD4+ T cells compared between uninfected and asymptomatic infected 
children at baseline. Box plots show medians and 10–90% whiskers. (g) TNF, IFN-γ, IL-5, IL-13, and IL-17 
cytokine responses of PBMCs to PfRBC stimulation, after background subtraction of responses to uninfected 
RBC, compared between uninfected and asymptomatic infected children at baseline. * indicates analysis with 
independent-samples T test (bar graphs) or Mann-Whitney U test (box plots) of baseline data. Analysis with 
linear mixed models of all time points together is shown in Supplementary Figure S1. *P ≤ 0.05. **P ≤ 0.01. 
***P ≤ 0.001.
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after admission for malaria and these levels appeared higher than those found in healthy controls16, 17. Also, con-
trolled infection of malaria-naïve adults results in an increase in γδ T cells18, 19. With our longitudinal approach, 
we could also detect a tendency for increased γδ T cells in subjects with a history of malaria infection during the 
study period. Along with relatively more γδ T cells, a cell type capable of strong responses to PfRBCs20, higher 
cytokine levels after PfRBC stimulation might have been expected in infected children, but TNF, IFN-γ, and IL-17 
responses were not significantly different from uninfected children.
Shifts among the Vδ1+ and Vδ2+ subsets of γδ T cells have been found to occur with malaria infection. In 
Ethiopian adults14 and Ghanaian children17, the increase in total γδ T cells as compared to healthy controls or 
upon malaria infection was mainly due to Vδ1+ cells. Furthermore, in Ugandan children, Vδ2+ cells decreased 
in numbers and showed decreased proliferation, cytokine production, and degranulation with repeated malaria 
exposure5, 6. Although we did not analyse these γδ T cell subsets separately, the increase in total γδ T cells in 
infected children in our study might also be due to Vδ1+ cells. As Vδ2+ but not Vδ1+ cells predominantly respond 
to in vitro PfRBC stimulation5, 6, an increase in Vδ1+ cells would not result in increased cytokine responses, which 
would be in line with our observations.
The percentages of Th1 and Th17 cells, but not of Th2 cells, were higher in infected than in uninfected chil-
dren. This is in line with our previous study, where Th1 levels were higher and Th2 levels unaltered in asympto-
matic infected Indonesian children as compared to uninfected children12. Despite these higher percentages of 
Th1 and Th17 cells in infected children, TNF, IFN-γ, and IL-17 cytokine responses to PfRBC stimulation were 
not significantly different between infected and uninfected children. Furthermore, despite the comparable Th2 
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Figure 2. Profiles of PD-1+ CD4+ T cells and Tregs and IL-10 production. (a,b,e,f,i) The percentage of cells 
or the expression level of markers on cells compared between uninfected and asymptomatic infected children 
at baseline. The expression levels are based on geomean fluorescent intensities (MFI). Bar graphs show means 
and standard errors of the mean. (c,d,g,h,j) The percentage of cells or the expression level of markers on cells 
in children uninfected at either the 9 or 21 months’ time point, plotted against the time period these children 
had been free of infection (see description Fig. 1). (k) IL-10 cytokine production by PBMCs in supernatant in 
response to in vitro PfRBC stimulation, after background subtraction of responses to uninfected RBC. l) IL-10 
cytokine production in children uninfected at either the 9 or 21 months’ time point, plotted against the time 
period these children had been uninfected.
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cell percentages, IL-5 and IL-13 cytokine responses were lower in infected children. In our previous study, TNF, 
IFN-γ, and IL-13 were also analysed and gave similar results12. In Papua New Guinea, TNF, IFN-γ, and IL-4 
cytokine responses to PfRBCs did not differ between infected and uninfected children21. Thus, IL-4 responses 
might differ from the other Th2 cytokines IL-5 and IL-13, or Th2 responses in general differed between our stud-
ies. In any case, the lack of enhanced TNF, IFN-γ, and IL-17 responses and the downregulated Th2 response in 
our current study might be related to the changes observed that are associated with immunoregulation amongst 
CD4+ T cells.
Indeed, asymptomatic infected children had relatively more phenotypically exhausted PD-1+ CD4+ T cells 
and produced more IL-10 in response to PfRBCs than uninfected children. In studies of children in Mali22 and 
Kenya9, malaria infection was also associated with PD-1+ CD4+ T cells. Furthermore, a recent study showed that 
PD-1+ CTLA4+ CD4+ T cells can coproduce IFN-γ and anti-inflammatory IL-10 in response to Plasmodium 
antigens, and can suppress proliferation of other CD4+ T cells after P. falciparum-specific and polyclonal stimula-
tion in a contact-dependent manner11. Besides PD-1+ T cells and IL-10 responses, infected children in our study 
had a higher percentage of Tregs expressing TNF-RII, which indicates higher suppressive capacity13. This is in 
accordance with our previous study amongst Indonesian children, where TNF-RII expression was higher during 
infection and decreased upon treatment12. Thus, the higher percentages of PD-1+ T cells and TNF-RII on Tregs 
and the higher IL-10 responses might have affected cytokine production upon PfRBC stimulation, resulting in 
similar PfRBC-induced TNF, IFN-γ, and IL-17 production and reduced IL-5 and IL-13 production by cells from 
infected children as compared to uninfected children. Additional markers and functional studies are required to 
determine the separate contributions of these cells and cytokines to immunoregulation and to determine whether 
our PD-1+ CD4+ T cells were truly exhausted.
Although displaying higher TNF-RII levels, Tregs nevertheless represented a lower proportion of CD4+ T cells 
in asymptomatic infected children than in uninfected children. This is in line with two previous studies amongst 
Indonesian children12, 23, but in contrast to studies amongst Indonesian23 and Peruvian24 adults where Treg per-
centages were comparable between asymptomatic infected and uninfected subjects. The differences between these 
studies might relate to differences in age or degree of exposure, as a study amongst Ugandan children showed that 
repeated malaria exposure in regions with high levels of malaria transmission results in a decline of Treg percent-
ages after a transient increase upon infection25.
Some of the differences between asymptomatic infected children and uninfected children were long-lasting, 
persisting after resolution of infection. For example, the higher levels of Th1 and Th17 cells and PD-1 on CD4+ 
T cells were long-lasting, as were the lower Treg levels, the higher number of Tregs expressing TNF-RII, and the 
higher IL-10 response. One interpretation could be that these profiles are enhanced by repeated malaria exposure 
and might thus be related to naturally acquired tolerance against symptomatic disease26.
Our findings shed new light on the dynamic changes of γδ T cells and CD4+ T cells during follow-up of 
asymptomatic children living in an area where malaria is endemic. Changes during asymptomatic malaria infec-
tion and following parasite clearance suggest short- and long-term effects of infection on γδ T cells and CD4+ 
T cells, as well as involvement of immunoregulation. The combination of these altered cellular immunological 
footprints could be intimately linked to asymptomatic carriage, immunity to malaria infection and disease, as 
well as responses to inflammatory insults. Studies involving larger sample sizes would be necessary to prove this.
Methods
Study population. The study described here is part of the ImmunoSPIN trial, which was conducted in the 
Ende district of Flores island in Indonesia27–29. This double-blind placebo-controlled trial was initiated in 2008 
by randomising households in the coastal village Nangapanda to receive either a single dose of 400 mg of the 
anthelminthic drug albendazole or a matching placebo, every three months over a two-year period. At baseline, 
9 months, and 21 months, venous blood was drawn from the participants for cellular assays and stored for deter-
mination of infection with Plasmodium. Included in the present analysis were a total of 123 school children, 
between 4 and 15 years old, with complete baseline data, and either asymptomatic Plasmodium-infected (includ-
ing multiple Plasmodium species) or uninfected. Individuals with symptomatic malaria were treated according to 
the current guidelines at the local health centre, and not included in this study. Clearance of asymptomatic infec-
tion during the trial could have occurred naturally or due to self-sought medical treatment. The ImmunoSPIN 
trail was performed in accordance with guidelines approved by the Committee of Medical Research Ethics of the 
University of Indonesia, and written informed consent was obtained from all participants’ parents or guardians.
Parasitology. Plasmodium infection was determined retrospectively by microscopy of blood slides and by 
quantitative real-time polymerase chain reaction (qPCR) of whole blood as described before30. P. falciparum, 
P. vivax, and P. malariae species were endemic; no children were infected with P. ovale. Helminth infection was 
determined by microscopy after formol-ether concentration for Trichuris trichiura and by multiplex qPCR for 
hookworm (Ancylostoma duodenale and Necator americanus), Ascaris lumbricoides, and Strongyloides stercoralis 
as described before29.
Cell isolation and stimulation. PBMCs were obtained by gradient centrifugation of heparinised venous 
blood over Ficoll (Apotheek AZL, Leiden, the Netherlands) in the field laboratory in Nangapanda, Indonesia. 
A part of the PBMCs was fixed for flow cytometric analysis and a part was stimulated for analysis of cytokine 
responses. 0.4 × 106 cells were stimulated in Nunc 96-well round bottom MicroWell plates with Nunclon delta 
surface (ThermoFisher Scientific, Waltham, MA, USA) in 200 µL 10% foetal bovine serum (FBS; Greiner Bio-One 
Frickenhausen, Germany)/RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) for 96 hours with 1 × 106 
PfRBCs, uninfected RBCs (uRBCs), or a medium control, after which supernatants were obtained.
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Cytokine measurements. Supernatants were kept at −20 °C and transported to Leiden, the Netherlands, 
where cytokine responses were quantified using Luminex cytokine kits (Biosource, Camarillo, CA, USA) and a 
Liquichip 200 Workstation (Qiagen, Venlo, the Netherlands) equipped with Liquichip analyser software (Qiagen, 
Venlo, the Netherlands). Cytokine levels below the assay’s detectable range were replaced by half the detection 
limit. The detection limits were 2.26 pg/mL for TNF, 0.68 pg/mL for IFN-γ, 0.16 pg/mL for IL-5, 0.44 pg/mL for 
IL-13, 0.60 pg/mL for IL-17, and 0.78 pg/mL for IL-10.
Flow cytometry. PBMC were fixed and permeabilised with FOXP3 Fixation/permeabilisation buffer (eBio-
science Inc., San Diego, CA, USA) for 1 hour at room temperature and cryopreserved in 10% FBS/10% dimethyl 
sulfoxide (DMSO; Merck Millipore)/RPMI at −20 °C. The samples were transported to Leiden, the Netherlands, 
where they were stored at −80 °C. The cells were thawed and stained for 30 minutes at 4 °C with the panel shown 
in Supplementary Table S3 in FOXP3 permeabilisation buffer (eBioscience) with FcγR-binding inhibitor (eBi-
oscience; 100x diluted). The samples were measured with a BD FACSCanto II flow cytometer (BD Biosciences, 
San Jose, CA, USA), equipped with a blue (488 nm Coherent Sapphire solid state laser, 20 mW laser output), red 
(633 nm JDSU 1144P-3581 HeNe laser, 17 mW laser output) and violet (405 nm Qioptiq iFLEX2000 solid state 
diode, 30 mW fibre power output) laser and detectors arranged as in Supplementary Table S4. The data was com-
pensated with BD CompBeads in BD FACSDiva 6 (BD Biosciences) and analysed with FlowJo 9 (FlowJo LLC, 
Ashland, OR, USA). The gating strategy is shown in Supplementary Figure S5.
Statistical analysis. Statistical analysis was performed in IBM SPSS Statistics version 21 for Windows 
(IBM Corp., Armonk, NY, USA) and graphs were made using GraphPad Prism version 7 for Windows 
(GraphPad Software, San Diego, CA, USA). (Two-sided) P values ≤ 0.05 were considered statistically signifi-
cant. Responses to PfRBC were assessed after subtraction of responses in the uRBC condition. Most base-
line data was log-transformed (log10(value +1)) to obtain normally distributed variables, and compared with 
independent-samples T tests. However, Mann-Whitney U tests were used for the transcription factor and 
cytokine data, which remained non-normally distributed.
Linear mixed models were used to obtain fixed predicted values of follow-up data, after confirming a nor-
mal distribution of residual variables. The models were based on restricted maximum likelihood (REML) esti-
mation and were run on log-transformed data. To compare infected and uninfected children over time as in 
Supplementary Figure S1, a model was used with current malaria infection status and time point as fixed effects. 
The time points were baseline, 9 months, and 21 months. Subject was included as a random effect with unstruc-
tured covariance type. For the analysis of time free of infection as in Fig. 1b, a model was used with time unin-
fected as fixed effect, and subject as a random effect with compound symmetry as covariance type. For this model, 
it was assumed that when a child was negative at two consecutive time points, it had been uninfected throughout 
this time period. For the comparison of current and previous malaria status as in Fig. 1c, a model was used with 
current malaria status and previous malaria status as fixed effects, and subject as a random effect with compound 
symmetry as covariance type.
Data availability. The datasets analysed during the current study are available from the corresponding 
author on reasonable request.
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